20th Annual Meeting of the

Save The Date
20th Annual Meeting of the

Oligonucleotide Therapeutics Society

October 6-9, 2024
Montreal, Canada

The Oligonucleotide Therapeutics Society (OTS) is an open, nonprofit forum to foster research and development of oligonucleotide therapeutics.

The Founders’ vision was to bring together the expertise from different angles of oligonucleotide research to create synergies and to bring the field of oligonucleotides to its full therapeutic potential. A new era of oligonucleotide drugs was envisioned that would change the landscape of therapeutic modalities.

Oligonucleotide therapeutics are now being used to successfully treat diseases and have the potential for widespread application. Over 100 treatments are in development for common conditions, including cancer and Alzheimer’s disease, as well as rare diseases. Incredibly, oligonucleotide therapeutics have also been used to create an individualized treatment for one single person with a rare, fatal disease.

The Annual Meeting is open to anyone interested or involved in oligonucleotide therapeutics. The OTS offers scholarships, awards and travel grants annually.

For details visit:

Registration and abstract submissions will open by early May and will be announced via email and social media.

All the Latest News


Follow-up Data Confirms That Inclisiran Provides Long-Term Reduction of LDL-Cholesterol


The First FDA Approval for a GalNAc-conjugated ASO

  • OTS Annual Meeting 2023

2023 Annual Meeting Highlights

November 13th, 2023|

We are pleased to note that this year’s annual Oligonucleotide Therapeutics Society meeting in Barcelona, Spain had the highest ...

Featured Member

Roberto El-Khoury, PhD

Roberto El-Khoury, PhD

Eli Lilly and Company

In my current role as an advisor at Eli Lilly and Company, I am working on developing oligonucleotide therapeutics for a range of targets. It is an incredible feeling to realize that a molecule I’ve worked may one day become a drug and save lives. It has equally been very rewarding to collaborate with scientists of diverse backgrounds and tackle projects together.


Membership is an opportunity to take advantage of an array of benefits that support the society’s mission to foster academia and industry-based research and development of oligonucleotide therapeutics, all at a reasonable rate!


The Oligonucleotide Therapeutics Society offers the opportunity for both members and non-members to apply for various awards to support the accomplishments of students, postdocs and young investigators.


Upcoming Webinars

Past Webinars

Job Board

If you are looking for great people in the field of oligonucleotide therapeutics, we encourage you to post your job openings on our job board. It’s free to post!  Just register as an employer and start posting your openings.

1 Job Found
Displayed Here: 1 - 1 Jobs

  • RSS Feed

The OTS Job Board allows you to, Post/Edit Jobs Review/Filter Resumes Manage Employer Profiles


Search the latest job postings in the field of oligonucleotide therapeutics. The OTS Job Board allows you to: Search Jobs, Upload Resume, Create Job Alerts